{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:51:08Z","timestamp":1762660268232,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s11606-022-07891-w","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:02:33Z","timestamp":1670364153000},"page":"733-737","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Buprenorphine Treatment Episodes During the First Year of COVID: a Retrospective Examination of Treatment Initiation and Retention"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1544-458X","authenticated-orcid":false,"given":"Bradley D.","family":"Stein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel K.","family":"Landis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flora","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan","family":"Saloner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Sorbero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew W.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,6]]},"reference":[{"issue":"32","key":"7891_CR1","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.15585\/mmwr.mm6932a1","volume":"69","author":"ME Czeisler","year":"2020","unstructured":"Czeisler ME, Lane RI, Petrosky E, et al. Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic - United States, June 24-30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1049-1057. https:\/\/doi.org\/10.15585\/mmwr.mm6932a1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"7891_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S2215-0366(20)30462-4","volume":"8","author":"M Taquet","year":"2021","unstructured":"Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8(2):130-140. https:\/\/doi.org\/10.1016\/S2215-0366(20)30462-4","journal-title":"Lancet Psychiatry."},{"key":"7891_CR3","unstructured":"Panchal N, Kamal R, Orgera K, et al. The Implications of COVID-19 for Mental Health and Substance Use. Kaiser Family Foundation. . https:\/\/www.kff.org\/coronavirus-covid-19\/issue-brief\/the-implications-of-covid-19-for-mental-health-and-substance-use\/"},{"key":"7891_CR4","unstructured":"Centers for Disease Control and Prevention. Early release of selected mental health estimates based on data from the January\u2013June 2019 National Health Interview Survey. . https:\/\/www.cdc.gov\/nchs\/data\/nhis\/earlyrelease\/ERmentalhealth-508.pdf"},{"issue":"5","key":"7891_CR5","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/jamapsychiatry.2020.4218","volume":"78","author":"J Friedman","year":"2021","unstructured":"Friedman J, Beletsky L, Schriger DL. Overdose-Related Cardiac Arrests Observed by Emergency Medical Services During the US COVID-19 Epidemic. JAMA Psych. 2021;78(5):562-564. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.4218","journal-title":"JAMA Psych"},{"key":"7891_CR6","doi-asserted-by":"publisher","unstructured":"Soares WE, 3rd, Melnick ER, Nath B, et al. Emergency Department Visits for Nonfatal Opioid Overdose During the COVID-19 Pandemic Across Six US Health Care Systems. Ann Emerg Med. 2021;https:\/\/doi.org\/10.1016\/j.annemergmed.2021.03.013","DOI":"10.1016\/j.annemergmed.2021.03.013"},{"key":"7891_CR7","unstructured":"Ahmad F, Rossen L, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics; 2020."},{"key":"7891_CR8","unstructured":"Mehrotra A, Chernew M, Linetsky D, Hatch H, Cutler D. The impact of the COVID-19 pandemic on outpatient visits: A rebound emerges. The Commonwealth Fund; 2020. Accessed December 16, 2020. https:\/\/www.commonwealthfund.org\/publications\/2020\/apr\/impact-covid-19-outpatient-visits"},{"key":"7891_CR9","unstructured":"Epic Health Research Network. Expansion of Telehealth during COVID-19 Pandemic. . https:\/\/ehrnprd.blob.core.windows.net\/wordpress\/pdfs\/Expansions-in-Telehealth-COVID-19"},{"key":"7891_CR10","unstructured":"Martin K, Kurowski D, Given P. The Impact of COVID-19 on the Use of Preventive Health Care. Health Care Cost Institute. . https:\/\/healthcostinstitute.org\/hcci-research\/the-impact-of-covid-19-on-the-use-of-preventive-health-care"},{"issue":"1","key":"7891_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.7326\/M20-1141","volume":"173","author":"GC Alexander","year":"2020","unstructured":"Alexander GC, Stoller KB, Haffajee RL, Saloner B. An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19. Ann Intern Med. 2020;173(1):57-58. https:\/\/doi.org\/10.7326\/M20-1141","journal-title":"Ann Intern Med"},{"key":"7891_CR12","doi-asserted-by":"publisher","unstructured":"White A, Lundahl B, Bryan MA, et al. Pregnancy and the Opioid Crisis: Heightened Effects of COVID-19. J Addict Med. 2021;https:\/\/doi.org\/10.1097\/ADM.0000000000000822","DOI":"10.1097\/ADM.0000000000000822"},{"issue":"3","key":"7891_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/08897077.2020.1787300","volume":"41","author":"G Cochran","year":"2020","unstructured":"Cochran G, Bruneau J, Cox N, Gordon AJ. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic. Subst Abus. 2020;41(3):269-274. https:\/\/doi.org\/10.1080\/08897077.2020.1787300","journal-title":"Subst Abus."},{"issue":"4","key":"7891_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/08897077.2020.1809609","volume":"41","author":"AM Gustavson","year":"2020","unstructured":"Gustavson AM, Gordon AJ, Kenny ME, et al. Response to coronavirus 2019 in Veterans Health Administration facilities participating in an implementation initiative to enhance access to medication for opioid use disorder. Subst Abus. 2020;41(4):413-418. https:\/\/doi.org\/10.1080\/08897077.2020.1809609","journal-title":"Subst Abus."},{"issue":"5","key":"7891_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/ADM.0000000000000786","volume":"15","author":"AT Kelley","year":"2021","unstructured":"Kelley AT, Dungan MT, Gordon AJ. Barriers and Facilitators to Buprenorphine Prescribing for Opioid Use Disorder in the Veterans Health Administration During COVID-19. J Addict Med. 2021;15(5):439-440. https:\/\/doi.org\/10.1097\/ADM.0000000000000786","journal-title":"J Addict Med"},{"key":"7891_CR16","doi-asserted-by":"publisher","unstructured":"Nguyen TD, Gupta S, Ziedan E, et al. Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic. JAMA Intern Med. 2020;https:\/\/doi.org\/10.1001\/jamainternmed.2020.7497","DOI":"10.1001\/jamainternmed.2020.7497"},{"key":"7891_CR17","doi-asserted-by":"publisher","unstructured":"Chalasani R, Shinabery JM, Goetz CT, et al. Buprenorphine Dispensing in Pennsylvania During the COVID-19 Pandemic, January to October 2020. J Gen Intern Med. 2021;https:\/\/doi.org\/10.1007\/s11606-021-07083-y","DOI":"10.1007\/s11606-021-07083-y"},{"issue":"4","key":"7891_CR18","doi-asserted-by":"publisher","first-page":"e216147","DOI":"10.1001\/jamanetworkopen.2021.6147","volume":"4","author":"JM Currie","year":"2021","unstructured":"Currie JM, Schnell MK, Schwandt H, Zhang J. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic. JAMA Netw Open. 2021;4(4):e216147. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.6147","journal-title":"JAMA Netw Open"},{"key":"7891_CR19","doi-asserted-by":"publisher","first-page":"108384","DOI":"10.1016\/j.jsat.2021.108384","volume":"129","author":"J Cantor","year":"2021","unstructured":"Cantor J, Dick AW, Haffajee R, et al. Use of buprenorphine for those with employer-sponsored insurance during the initial phase of the COVID-19 pandemic. J Subst Abuse Treat 2021;129:108384. https:\/\/doi.org\/10.1016\/j.jsat.2021.108384","journal-title":"J Subst Abuse Treat"},{"key":"7891_CR20","doi-asserted-by":"publisher","first-page":"108486","DOI":"10.1016\/j.drugalcdep.2020.108486","volume":"219","author":"CM Jones","year":"2021","unstructured":"Jones CM, Guy GP, Jr., Board A. Comparing actual and forecasted numbers of unique patients dispensed select medications for opioid use disorder, opioid overdose reversal, and mental health, during the COVID-19 pandemic, United States, January 2019 to May 2020. Drug Alcohol Depend. 2021;219:108486. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108486","journal-title":"Drug Alcohol Depend"},{"issue":"23","key":"7891_CR21","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1001\/jama.2020.22154","volume":"324","author":"JD Cance","year":"2020","unstructured":"Cance JD, Doyle E. Changes in Outpatient Buprenorphine Dispensing During the COVID-19 Pandemic. JAMA. 2020;324(23):2442-2444. https:\/\/doi.org\/10.1001\/jama.2020.22154","journal-title":"JAMA"},{"key":"7891_CR22","doi-asserted-by":"publisher","first-page":"108272","DOI":"10.1016\/j.jsat.2020.108272","volume":"124","author":"L Wang","year":"2021","unstructured":"Wang L, Weiss J, Ryan EB, Waldman J, Rubin S, Griffin JL. Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic. J Subst Abuse Treat. 2021;124:108272. https:\/\/doi.org\/10.1016\/j.jsat.2020.108272","journal-title":"J Subst Abuse Treat"},{"key":"7891_CR23","doi-asserted-by":"publisher","unstructured":"Samuels EA, Khatri UG, Snyder H, Wightman RS, Tofighi B, Krawczyk N. Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19. J Gen Intern Med. 2022;https:\/\/doi.org\/10.1007\/s11606-021-07249-8","DOI":"10.1007\/s11606-021-07249-8"},{"key":"7891_CR24","unstructured":"IQVIA: Real World Data and Insights. Accessed July 13, 2020. https:\/\/www.iqvia.com\/solutions\/real-world-evidence\/real-world-data-and-insights"},{"key":"7891_CR25","doi-asserted-by":"publisher","unstructured":"Saloner B, Krawczyk N, Solomon K, et al. Experiences with Substance Use Disorder Treatment During the COVID-19 Pandemic: Findings from a Multistate Survey. International Journal of Drug Policy. 2021;https:\/\/doi.org\/10.1016\/j.drugpo.2021.103537","DOI":"10.1016\/j.drugpo.2021.103537"},{"key":"7891_CR26","doi-asserted-by":"publisher","first-page":"108462","DOI":"10.1016\/j.jsat.2021.108462","volume":"127","author":"J Cantor","year":"2021","unstructured":"Cantor J, Kravitz D, Sorbero M, et al. Trends in visits to substance use disorder treatment facilities in 2020. J Subst Abuse Treat 2021;127:108462. https:\/\/doi.org\/10.1016\/j.jsat.2021.108462","journal-title":"J Subst Abuse Treat"},{"key":"7891_CR27","doi-asserted-by":"publisher","unstructured":"Andraka-Christou B, Bouskill K, Haffajee RL, et al. Common themes in early state policy responses to substance use disorder treatment during COVID-19. Am J Drug Alcohol Abuse 2021:1-11. https:\/\/doi.org\/10.1080\/00952990.2021.1903023","DOI":"10.1080\/00952990.2021.1903023"},{"key":"7891_CR28","doi-asserted-by":"publisher","unstructured":"Pessar SC, Boustead A, Ge Y, Smart R, Pacula RL. Assessment of State and Federal Health Policies for Opioid Use Disorder Treatment During the COVID-19 Pandemic and Beyond. JAMA Health Forum. 2021;2(11)https:\/\/doi.org\/10.1001\/jamahealthforum.2021.3833","DOI":"10.1001\/jamahealthforum.2021.3833"},{"key":"7891_CR29","unstructured":"Long K, Manz J, Mette E. States rapidly build their telehealth capacity to deliver opioid use disorder treatment. Covid-19 State Action Center. National Academy for State Health Policy; 2020. April 13. Accessed March 29, 2022. https:\/\/www.nashp.org\/states-rapidly-build-their-telehealth-capacity-to-deliver-opioid-use-disorder-treatment\/"},{"key":"7891_CR30","doi-asserted-by":"publisher","unstructured":"Tilhou AS, Dague L, Saloner B, Beemon D, Burns M. Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 Pandemic. JAMA Health Forum. 2022;3(3)https:\/\/doi.org\/10.1001\/jamahealthforum.2022.0093","DOI":"10.1001\/jamahealthforum.2022.0093"},{"key":"7891_CR31","unstructured":"H.R.6201 - Families First Coronavirus Response Act, Public Law No: 116-127 (2020)."},{"key":"7891_CR32","doi-asserted-by":"publisher","unstructured":"Chen AY, Powell D, Stein BD. Changes in Buprenorphine and Methadone Supplies in the US During the COVID-19 Pandemic. JAMA Network Open. 2022;5(7)https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.23708","DOI":"10.1001\/jamanetworkopen.2022.23708"},{"key":"7891_CR33","doi-asserted-by":"publisher","first-page":"109089","DOI":"10.1016\/j.drugalcdep.2021.109089","volume":"228","author":"I Cabreros","year":"2021","unstructured":"Cabreros I, Griffin BA, Saloner B, Gordon AJ, Kerber R, Stein BD. Buprenorphine prescriber monthly patient caseloads: An examination of 6-year trajectories. Drug Alcohol Depend. 2021;228:109089. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.109089","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"7891_CR34","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hec.3982","volume":"29","author":"CA Yee","year":"2020","unstructured":"Yee CA, Legler A, Davies M, Prentice J, Pizer S. Priority access to health care: Evidence from an exogenous policy shock. Health Econ. Mar 2020;29(3):306-323. https:\/\/doi.org\/10.1002\/hec.3982","journal-title":"Health Econ."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-022-07891-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-022-07891-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-022-07891-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:08:02Z","timestamp":1701821282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-022-07891-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,6]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["7891"],"URL":"https:\/\/doi.org\/10.1007\/s11606-022-07891-w","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"type":"print","value":"0884-8734"},{"type":"electronic","value":"1525-1497"}],"subject":[],"published":{"date-parts":[[2022,12,6]]},"assertion":[{"value":"14 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}